Resources & Insights

Learn more about what makes working at PharPoint Research unique and get to know biostatistics manager Carson M.

Patient diversity, equity, and inclusion (DEI) in clinical trials is an important focus for both regulatory authorities and other industry stakeholders.

In this article , we discuss how CRAs review adverse events, including the role of a CRA and what documentation is needed.

What makes PharPoint’s clinical operations team unique? PharPoint clinical research associate (CRA) Sophie chats with us in this short clip.

PharPoint’s clinical team members have extensive experience within CHF trials. Our team has found that one of the biggest challenges these studies encounter is the issue of non-compliance.

We discuss six techniques from PharPoint’s enrollment toolkit, deployed to help keep our clients study enrollment on track.

Get to know Paul Johnson, Executive Director of Strategy Development and head of clinical consulting at PharPoint Research.

Worried about working with a CRO for your upcoming trial? A transparent proposal process, clear upfront communication, and a plan for ongoing monitoring can help you develop a better relationship with your CRO.

Learn more about PharPoint’s Associate Director of Medical Writing, Samia, including her career journey and what she think makes PharPoint unique.

A strategic clinical development plan (CDP) can help Sponsors optimize their new drug programs. What should you include in your CDP?